erlotinib hydrochloride has been researched along with phleomycins in 1 studies
| Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (phleomycins) | Trials (phleomycins) | Recent Studies (post-2010) (phleomycins) |
|---|---|---|---|---|---|
| 4,353 | 786 | 3,033 | 168 | 0 | 24 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fadlalla, K; Gales, DN; Manne, U; Putcha, BD; Samuel, T | 1 |
1 other study(ies) available for erlotinib hydrochloride and phleomycins
| Article | Year |
|---|---|
Variable NF-κB pathway responses in colon cancer cells treated with chemotherapeutic drugs.
Topics: Antineoplastic Agents; Camptothecin; Cell Line, Tumor; Colonic Neoplasms; Erlotinib Hydrochloride; Fluorouracil; Gene Expression Regulation, Neoplastic; HCT116 Cells; Humans; NF-kappa B; Organoplatinum Compounds; Oxaliplatin; Phleomycins; Quinazolines; Signal Transduction | 2014 |